Article
The Effect of Fibrates on Kidney Function and Chronic Kidney Disease Progression: Protocol for a Systematic Review.
2020-11-12
Abstract excerpt
<title>Abstract</title> <p><bold>Background/Objectives: </bold>Fibrates reduce cardiovascular risk in the general population and in patients with chronic kidney disease (CKD). Although, they are commonly used as second-line agents in addition to statins for hypertriglyceridemia, their use in CKD is limited due to a decrease of glomerular filtration rate (GFR) at treatment initiation. This change in GFR is reversi...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f9c6e343-cfac-56d7-9ad3-60184d2ed467
- DOI
- 10.21203/rs.3.rs-104160/v1